Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/125898
Title: A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients
Author: Cano, Ainara
Mariño, Zoe
Millet Aguilar-Galindo, Òscar
Martínez Arranz, Ibon
Navasa, Miquel
Falcón-Pérez, Juan M.
Pérez Cormenzana, Miriam
Caballeria Rovira, Joan
Embade, Nieves
Forns, Xavier
Bosch, Jaume
Castro, Azucena
Mato, José M.
Keywords: Trasplantament hepàtic
Hepatitis C
Cirrosi hepàtica
Diagnòstic molecular
Hepatic transplantation
Hepatitis C
Hepatic cirrhosis
Molecular diagnosis
Issue Date: 5-Sep-2017
Publisher: Nature Publishing Group
Abstract: Liver fibrosis must be evaluated in patients with hepatitis C virus (HCV) after liver transplantation because its severity affects their prognosis and the recurrence of HCV. Since invasive biopsy is still the gold standard to identify patients at risk of graft loss from rapid fibrosis progression, it becomes crucial the development of new accurate, non-invasive methods that allow repetitive examination of the patients. Therefore, we have developed a non-invasive, accurate model to distinguish those patients with different liver fibrosis stages. Two hundred and three patients with HCV were histologically classified (METAVIR) into five categories of fibrosis one year after liver transplantation. In this cross-sectional study, patients at fibrosis stages F0-F1 (n = 134) were categorised as "slow fibrosers" and F2-F4 (n = 69) as "rapid fibrosers". Chloroform/methanol serum extracts were analysed by reverse ultra-high performance liquid chromatography coupled to mass spectrometry. A diagnostic model was built through linear discriminant analyses. An algorithm consisting of two sphingomyelins and two phosphatidylcholines accurately classifies rapid and slow fibrosers after transplantation. The proposed model yielded an AUROC of 0.92, 71% sensitivity, 85% specificity, and 84% accuracy. Moreover, specific bile acids and sphingomyelins increased notably along with liver fibrosis severity, differentiating between rapid and slow fibrosers.
Note: Reproducció del document publicat a: https://doi.org/10.1038/s41598-017-10807-y
It is part of: Scientific Reports, 2017, vol. 7, num. 1, p. 10497
Related resource: https://doi.org/10.1038/s41598-017-10807-y
URI: http://hdl.handle.net/2445/125898
ISSN: 2045-2322
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
675950.pdf1.76 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons